Jubilant Life Sciences has informed that a meeting of the board of directors of the company will be held on May 07, 2012, to consider the audited financial results of the company for the year ended March 31, 2012 and for recommendation of dividend for the year ended March 31, 2012.
The above information is part of company’s filing submitted to the BSE.